-
Archives
- February 2020
- August 2018
- July 2018
- June 2018
- July 2017
- May 2017
- January 2017
- October 2016
- June 2016
- March 2016
- January 2016
- November 2015
- August 2015
- July 2015
- June 2015
- May 2015
- June 2014
- May 2014
- April 2014
- December 2012
- September 2012
- July 2012
- May 2012
- April 2012
- February 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
-
Meta
Monthly Archives: May 2017
SNMMI Comments to FDA on Compounding
SNMMI submitted comments to the FDA on draft guidance “Compounding and Repackaging of Radiopharmaceuticals by State-Licensed Nuclear Pharmacies.” The guidance explains that, under current law, radiopharmaceuticals compounded or repackaged by state-licensed nuclear pharmacies and federal facilities are subject to all … Continue reading
Posted in PET Drugs
Leave a comment
